Peritoneal Cancer: Symptoms, Diagnosis, and Treatment

The underlying cause of your abdominal pain may be far more complex than it seems. Peritoneal cancer is a rare but serious condition that requires close attention during diagnosis and treatment. In this guide, you’ll find detailed information on the causes, symptoms, stages, and modern treatment options for peritoneal cancer.

This type of cancer is uncommon, difficult to diagnose, and often presents symptoms only in its advanced stages. For this reason, early detection plays a crucial role in treatment success.

What Is Peritoneal Cancer?

Peritoneal cancer is a malignant condition that develops in the peritoneum—the thin tissue lining the abdominal cavity—or spreads to it from other organs.

The peritoneum surrounds and protects the digestive organs. When cancer forms in this membrane, symptoms usually appear late, making early diagnosis difficult. However, when detected in its early stages, treatment outcomes can be significantly more favorable.

How Does Peritoneal Cancer Develop?

Peritoneal cancer begins with genetic mutations that cause uncontrolled cell growth. These mutations alter the structure of the cells in the peritoneal lining, leading to tumor formation.

This lining protects the abdominal organs and serves an essential role in the digestive system. When cell growth becomes uncontrolled in this area, tumor tissues can form. In some cases, the process begins with metastasis from other cancers such as ovarian, gastric, or colorectal cancers.

Causes of Peritoneal Cancer

Peritoneal cancer is often secondary, meaning it results from the spread of cancer originating in another organ. Ovarian, stomach, and colon cancers frequently metastasize to the peritoneum. These secondary tumors create new cancer sites within the peritoneal tissue, complicating the disease's progression.

Primary peritoneal cancer, which starts directly in the peritoneal lining, is much rarer. Its development may be linked to genetic predispositions, including BRCA1 and BRCA2 gene mutations, and environmental factors such as long-term exposure to harmful substances like asbestos.

Symptoms of Peritoneal Cancer

Symptoms of peritoneal cancer typically develop slowly and become more noticeable in advanced stages. Common signs include persistent abdominal bloating, indigestion, loss of appetite, and unexplained weight loss. Some patients may also experience abdominal pain, constipation, or diarrhea.

In later stages, fluid accumulation in the abdomen (ascites) can occur due to peritoneal irritation. This may lead to a sensation of fullness, shortness of breath, and limited mobility. Because these symptoms are similar to those of other gastrointestinal disorders, accurate diagnosis often requires imaging and biopsy.

Types of Peritoneal Cancer

Peritoneal cancer is categorized into two main types based on its origin: primary peritoneal cancer and secondary (metastatic) cancers. Primary cancer originates within the peritoneal lining itself, while secondary cancers spread to the peritoneum from another organ.

Primary Peritoneal Cancer

Primary peritoneal cancer shares many similarities with ovarian cancer, particularly in women. However, in this case, the peritoneum develops cancer despite the ovaries appearing normal.

• Histological resemblance: It closely resembles ovarian cancer under microscopic examination, though its origin is the peritoneum.

• More common in women: Especially prevalent in postmenopausal women.

• BRCA mutation link: Individuals with BRCA1 or BRCA2 gene mutations have an increased risk.

• Surgical diagnosis: Often difficult to detect through imaging alone; diagnosis usually requires surgical exploration and biopsy.

Secondary (Metastatic) Peritoneal Cancer

Secondary peritoneal cancers arise when malignancies from other organs spread to the peritoneum. This typically occurs in the advanced stages of cancer.

• Most common primary sources: Stomach, colon, pancreas, and ovarian cancers are known to metastasize to the peritoneum.

• Spread within the abdominal cavity: Cancer cells disseminate across the peritoneal surface, leading to fluid accumulation and tumor growth.

• Treatment approach: Therapy is designed to target both the original tumor and the peritoneal metastases.

• Variable prognosis: The outcome depends on the type of primary cancer and the extent of peritoneal spread.

Stages of Peritoneal Cancer

Peritoneal cancer is classified into stages based on how far the disease has progressed. Each stage presents different symptom intensities, treatment options, and prognoses. Early diagnosis can slow progression, while late detection may limit treatment success.

Staging generally assesses whether the tumor remains localized within the peritoneum, has spread throughout the abdominal cavity, or has metastasized to distant organs. Clinical findings and imaging results are the main criteria for staging.

Stage 1: Localized Cancer

In stage 1 peritoneal cancer, the tumor is confined to a limited area of the peritoneal lining without spreading to other tissues or organs. Diagnosis at this stage is rare, as symptoms are often mild or absent.

• Surgical intervention is most effective: The tumor can be completely removed, and the recovery rate is high.

• Symptoms are vague: Bloating, mild abdominal discomfort, and decreased appetite may occur.

• Imaging plays a critical role: Early detection relies on ultrasound and CT scans.

Stages 2–3: Regional Spread

At these stages, cancer has spread more extensively within the peritoneum and may have reached nearby tissues. In stage 3, tumor implants and fluid buildup (ascites) may be present throughout the abdominal cavity. Treatment typically involves surgery, chemotherapy, and HIPEC.

• Symptoms become more pronounced: Fluid accumulation, shortness of breath, and rapid weight loss are common.

• Treatment requires a multidisciplinary approach: Cytoreductive surgery and heated chemotherapy (HIPEC) are combined.

• Survival rates vary: Outcomes depend on treatment response, tumor burden, and overall health.

Stage 4: Distant Metastasis

This is the most advanced stage, where cancer has spread beyond the abdominal cavity—often to the liver, lungs, or lymph nodes. Treatment at this stage focuses on symptom management and extending life expectancy rather than complete cure.

• Systemic treatments are prioritized: Chemotherapy and targeted therapies become central.

• Palliative care is crucial: Pain control, nutritional support, and psychological care play vital roles.

• Focus is on quality of life: Even when tumor burden is reduced, a cure is often unlikely.

Risk Factors for Peritoneal Cancer

Peritoneal cancer is more likely to develop in individuals with genetic predisposition or exposure to certain environmental or medical factors. While risk profiles differ between primary and secondary forms, many risk factors are shared.

The most common risk factors include:

• BRCA1 and BRCA2 gene mutations: Especially relevant in women at risk for primary peritoneal cancer.

• Family history of ovarian or colon cancer: Genetic inheritance increases susceptibility.

• Asbestos exposure: Particularly in occupations like construction and textiles, this substance can trigger peritoneal malignancies.

• Advanced age: Risk increases significantly in individuals over 60.

• Chronic inflammation and previous abdominal surgeries: Tissue damage may facilitate malignant transformation.

Diagnosis of Peritoneal Cancer

Due to its subtle progression, peritoneal cancer is often diagnosed late. Since symptoms mimic other gastrointestinal issues, a definitive diagnosis requires thorough investigation. Early detection significantly influences treatment success and life expectancy.

Diagnostic methods include:

• Imaging techniques: CT scans, MRI, and ultrasound help identify fluid buildup, masses, and tumor implants within the abdomen.

• Tumor markers: Blood tests such as CA-125 provide biological indicators of tumor presence.

• Laparoscopic biopsy: A minimally invasive surgical procedure to collect tissue samples for definitive diagnosis.

• Cytology: Examination of cells from abdominal fluid (ascites) under a microscope to assess disease spread.

Treatment of Peritoneal Cancer

The treatment of peritoneal cancer requires a multidisciplinary approach. A personalized treatment plan should be developed based on the type of cancer (primary or secondary), its stage, and the patient's overall health status. The goal of treatment is not only to combat the tumor but also to improve quality of life.

Main treatment methods include:

• Cytoreductive surgery: Removal of all visible tumors and nodules from the abdominal cavity.

• HIPEC (Hyperthermic Intraperitoneal Chemotherapy): Warm chemotherapy solution is administered directly into the abdomen to target microscopic cancer cells.

• Systemic chemotherapy: Drug therapy that circulates throughout the body, often used in advanced stages.

• Targeted therapy and immunotherapy: Selected based on genetic profiling, these therapies include smart drugs and immune system boosters.

• Palliative care: Focuses on relieving pain, managing nausea, and providing nutritional support to enhance comfort and quality of life.

What Should Patients with Peritoneal Cancer Be Aware Of?

Patients living with peritoneal cancer should strive for balance in their physical, emotional, and social lives throughout treatment. This improves adherence to therapy and supports the recovery process.

Key considerations include:

• Nutrition: Adopt a balanced diet rich in protein and antioxidants, and avoid processed foods.

• Hydration: Maintaining adequate fluid intake is crucial for abdominal fluid balance and overall metabolic function.

• Infection prevention: As chemotherapy can weaken the immune system, strict hygiene practices are essential.

• Psychological support: Cancer care is not only physical but also emotional. Psychoncology counseling is highly recommended.

• Regular monitoring: Routine imaging and blood tests play a vital role in tracking treatment response.

Early Diagnosis Saves Lives in Peritoneal Cancer

Although rare, peritoneal cancer can have serious consequences and requires careful monitoring. Because symptoms often develop insidiously, diagnosis may be delayed, which leads to detection at more advanced stages.

With early diagnosis, accurate staging, and appropriate treatment approaches, both survival rates and quality of life can be significantly improved. If you experience persistent abdominal bloating, unexplained weight loss, or digestive issues, it is essential to consult a specialist. Raising awareness about peritoneal cancer can lead to earlier detection and more successful treatment outcomes.

Online Oncology Specialist Support With Happ Health

Peritoneal cancer is a serious disease that may progress with symptoms such as abdominal swelling, unexplained weight loss, digestive problems and fluid accumulation in the abdomen. Therefore, specialist evaluation should not be delayed if complaints persist for a long time or occur together with an existing cancer history.

Happ Health, as a digital health platform, offers a solution that provides access to online oncology specialist consultations. You can manage your health process more consciously by receiving specialist support for suspected peritoneal cancer, the need for a second opinion after diagnosis, treatment process or follow-up planning.